Related Experiment Video
Updated: May 17, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case report
Domenico De Berardis1, Nicola Serroni, Stefano Marini
1NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", ASL 4, 64100 Teramo, Italy ; Department of Neurosciences and Imaging, Chair of Psychiatry, University "G. D'Annunzio", 66100 Chieti, Italy.
Abstract:
Obsessive-compulsive disorder (OCD) is a chronic condition characterized by obsessions or compulsions that cause distress or interfere with functioning. Selective serotonin reuptake inhibitors are the first-line strategy in the treatment of OCD, but approximately 40% to 60% of patients with OCD fail to respond to them. Several augmentation strategies have been proposed, including the use of atypical antipsychotics and antidepressant combinations. In the present paper we describe the case of a young female patient suffering from severe treatment-resistant OCD who remitted as a result of agomelatine augmentation of escitalopram therapy.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Electroconvulsive Therapy
Antidepressant Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Obsessive-Compulsive Disorder
Drug Therapy
Antianxiety Medications

